Adents, a Paris, France-based serialization and traceability software specialist, raised €12m in funding.
Backers included existing investors NAXICAP Partners, Omnes Capital and CapHorn Invest.
The company will use the funds to further develop its global network of solution partners and expand its presence in new international markets.
Founded in 2007 by Christophe Devins, CEO, Adents provides product identification and traceability software for pharmaceutical companies and contract manufacturers to adapt to market changes and comply with regulations on drug traceability. The company’s suite utilizes standardized software compatible with both information systems (ERP, MES) and existing production and packaging equipment.
Adents operates in Europe, Canada, and in the United States.